Clinical trial
Research on Efficacy and Tolerability of Proteoglycan F in the Treatment of Knee Osteoarthritis: a Prospective, Randomized, Double-blind Controlled Trial
NCT04998825 is registered in ClinicalTrials.gov with National Geriatric Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Research on Efficacy and Tolerability of Proteoglycan F in the Treatment of Knee Osteoarthritis: a Prospective, Randomized, Double-blind Controlled Trial
- Lead sponsor
- National Geriatric Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2021
- Completion date
- May 30, 2022
- Enrollment
- 72 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
primary osteoarthritis of knee nos